Deoxyfluoroguanosine

Drug Profile

Deoxyfluoroguanosine

Alternative Names: Fluorodeoxyguanosine

Latest Information Update: 21 Jan 2008

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antivirals; Nucleosides; Small molecules
  • Mechanism of Action DNA-directed RNA polymerase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Influenza virus infections

Most Recent Events

  • 21 Jan 2004 Discontinued for Influenza virus infections in United Kingdom (unspecified route)
  • 29 Nov 2000 No-Development-Reported for Influenza virus infections in United Kingdom (Unknown route)
  • 20 Aug 1999 A study has been added to the antimicrobial activities section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top